Elevated Serum Interleukin-6 Predicts Favorable Response to Immunosuppressive Therapy in Children With Aplastic Anemia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Immunosuppressive therapy (IST) is the standard treatment for aplastic anemia (AA) children who lack a sibling donor, but the clinical response rate to IST varies. Predictors of response to IST are valuable for stratifying AA patients and making clinical decisions.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Pediatr Hematol Oncol

Title: Journal of pediatric hematology/oncology

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1536-3678

ISSN (Print): 1077-4114

Publication date (Electronic): November 2017

Volume: 39

Issue: 8

Affiliations

[1 ] Department of Pediatrics, Tongji Hospital Affiliated to Tongji University, Shanghai, China.

Article

Publisher Item ID: 00043426-201711000-00007

DOI: 10.1097/MPH.0000000000000942

PubMed ID: 29068868

SO-VID: 7c9b6a5f-5e49-40a0-baa8-01e45cc11838

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by